`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Page 1
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
`
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
` - - - - - - - - - - - - - - - x
`
` LIQUIDIA TECHNOLOGIES, INC. :
`
` Petitioner :
`
` vs. : IPR2020-0070
`
` UNITED THERAPEUTICS : U.S. Patent No.
`
` CORPORATION : 9,604,901
`
` Patent Owner :
`
` - - - - - - - - - - - - - - - x
`
` VIRTUAL VIDEOTAPED DEPOSITION OF: RODOLFO PINAL, Ph.D.
`
` DATE: Wednesday, February 10, 2021
`
` TIME: 11:09 a.m.
`
` LOCATION: Remote Proceedings
`
` REPORTED BY: Denise M. Brunet, RPR
`
` Reporter/Notary
`
` Veritext Legal Solutions
`
` 1250 Eye Street, N.W., Suite 350
`
` Washington, D.C. 20005
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 1
`
`
`
` A P P E A R A N C E S
`
`Page 2
`
` On behalf of Liquidia Technologies:
`
` DEEPA KANNAPPAN, ESQUIRE
`
` Cooley, LLP
`
` 3175 Hanover Street
`
` Palo Alto, California 94304
`
` (650) 843-5673
`
` dkannappan@cooley.com
`
` SANYA SUKDUANG, ESQUIRE
`
` DOUGLAS CHEEK, ESQUIRE
`
` Cooley, LLP
`
` 1299 Pennsylvania Avenue, Northwest
`
` Washington, D.C. 20004
`
` (202) 776-2982
`
` ssukduang@cooley.com
`
` (Appearances continued on the next page.)
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 2
`
`
`
` A P P E A R A N C E S ( c o n t i n u e d ) :
`
`Page 3
`
` O n b e h a l f o f U n i t e d T h e r a p e u t i c s C o r p o r a t i o n :
`
` R I C H A R D T O R C Z O N , E S Q U I R E
`
` D O U G C A R S T E N , E S Q U I R E
`
` W i l s o n S o n s i n i
`
` 1 7 0 0 K S t r e e t , N o r t h w e s t
`
` W a s h i n g t o n , D . C . 2 0 0 0 6
`
` ( 2 0 2 ) 9 7 3 - 8 8 1 1
`
` r t o r c z o n @ w s g r . c o m
`
` D A N I E L R . S H E L T O N , E S Q U I R E
`
` F o l e y & L a r d n e r , L L P
`
` 9 7 5 P a g e M i l l R o a d
`
` P a l o A l t o , C a l i f o r n i a 9 4 3 0 4
`
` ( 6 5 0 ) 2 5 1 - 1 1 1 9
`
` A L S O P R E S E N T : J e f f r e y W i n k l e r
`
` G r a c e W i n s c h e l
`
` S a m u e l F r a n c i s , V i d e o g r a p h e r
`
` J o s h H o e p p n e r , C o n c i e r g e
`
` ( A l l p a r t i e s a p p e a r i n g r e m o t e l y . )
`
`1
`
`2 3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`1 0
`
`1 1
`
`1 2
`
`1 3
`
`1 4
`
`1 5
`
`1 6
`
`1 7
`
`1 8
`
`1 9
`
`2 0
`
`2 1
`
`2 2
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 3
`
`
`
` C O N T E N T S
`
` EXAMINATION BY: PAGE
`
` Counsel for Petitioner 6
`
`Page 4
`
` DEPOSITION EXHIBITS: MARKED
`
` 2025 - Pinal declaration 32
`
` 1001 - U.S. patent 9,604,901 52
`
` 1005 - Decision in SteadyMed v. UTC 128
`
` (Exhibits attached to transcript.)
`
`1
`
`2
`
`3
`
`4 5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 4
`
`
`
`Page 5
`
` P R O C E E D I N G S
`
` THE VIDEOGRAPHER: Good morning. We're
`
` going on the record at 11:09 a.m. on
`
` February 10th, 2021. This is the remote
`
` video-recorded deposition of Dr. Rodolfo Pinal
`
` taken in the matter of Liquidia Technologies,
`
` Inc., petitioner, versus United Therapeutics
`
` Corp., patent owner, filed in the United States
`
` Patent and Trademark Office, before the Patent
`
` Trial and Appeal Board, IPR number 2020-00770.
`
` My name is Samuel Francis from the firm
`
` Veritext Legal Solutions. The court reporter is
`
` Ms. Denise Brunet from the firm Veritext Legal
`
` Solutions.
`
` Will counsel please state their
`
` appearances and affiliations for the record.
`
` MS. KANNAPPAN: This is Deepa Kannappan
`
` from Cooley, LLP on behalf of petitioner Liquidia
`
` Technologies. With me are Sanya Sukduang and
`
` Douglas Cheek, also of Cooley, LLP. And possibly
`
` joining is our expert, Dr. Jeffrey Winkler.
`
` MR. TORCZON: And this is Richard Torczon
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 5
`
`
`
` of Wilson Sonsini representing United
`
` Therapeutics. With me on the line is Grace
`
` Winschel, also of Wilson Sonsini, and Dan Shelton
`
`Page 6
`
` from Foley.
`
` THE VIDEOGRAPHER: Will the court
`
` reporter please swear in the witness.
`
` WHEREUPON,
`
` RODOLFO PINAL, Ph.D.
`
` called as a witness, and having been remotely
`
` sworn by the notary public, was examined and
`
` testified as follows:
`
` THE VIDEOGRAPHER: You may proceed,
`
` Counsel.
`
` EXAMINATION BY COUNSEL FOR PETITIONER
`
` BY MS. KANNAPPAN:
`
` Q Good morning. Can you please state your
`
` name for the record.
`
` A Good morning. My name is Rodolfo Pinal.
`
` R-O-D-O-L-F-O, P-I-N-A-L.
`
` Q And where do you presently reside,
`
` Dr. Pinal?
`
` A I reside in West Lafayette, Indiana.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 6
`
`
`
`Page 7
`
` Q Is that where you are currently?
`
` A Correct.
`
` Q What's your business address?
`
` A 575 Stadium Mall Drive, West Lafayette,
`
` Indiana, 47907.
`
` Q Are you taking this deposition from your
`
` business address?
`
` A The same campus, but in a different
`
` building.
`
` Q And what's your current position
`
` employment-wise?
`
` A I am associate professor of industrial
`
` and physical pharmacy.
`
` Q Are you a professor at a particular
`
` university?
`
` A At Purdue University, correct.
`
` Q Do you understand that you just took an
`
` oath to tell the truth today?
`
` A I do.
`
` Q Is there any reason why you can't provide
`
` truthful testimony here today?
`
` A No, there is no reason.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 7
`
`
`
` Q You're not on any medication or anything
`
` else that could affect the truthfulness of your
`
`Page 8
`
` testimony?
`
` A I am not.
`
` Q Have you been deposed before, Dr. Pinal?
`
` A Yes, I have.
`
` Q How many times have you been deposed?
`
` A More than ten times.
`
` Q When was the most recent time?
`
` A If I believe -- if I remember correctly,
`
` must have been 2019, possibly 2018.
`
` Q What was the subject matter of that case?
`
` A It was a patent case involving a
`
` pharmaceutical product.
`
` Q Do you remember what the technology of
`
` that pharmaceutical product was?
`
` A In general terms, it was technology
`
` related to an injectable product used for treating
`
` cancer.
`
` Q Was the patent about a specific product
`
` or was it about the method of administration?
`
` MR. TORCZON: Object to form.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 8
`
`
`
` THE WITNESS: The very last deposition
`
` that I had, I cannot recall exactly, but I believe
`
` this was not on the method of use but an actual
`
`Page 9
`
` product itself.
`
` BY MS. KANNAPPAN:
`
` Q So you said earlier that you've been
`
` deposed more than ten times. How many of those
`
` depositions related to patent cases?
`
` A All of them.
`
` Q When was the earliest that you served as
`
` an expert witness for a patent case?
`
` A It was in 2013.
`
` Q So is it accurate to say that all of your
`
` depositions have happened between 2013 and 2019
`
` except for this one?
`
` A Correct.
`
` Q Just some ground rules before we
`
` continue, just about remote depositions, because
`
` they're a little different from in-person
`
` depositions. It's really important, as the court
`
` reporter was saying earlier, that you wait for me
`
` to completely finish my question before you
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 9
`
`
`
`Page 10
`
` answer, and I will do the same while you finish
`
` answering so that we don't talk over each other.
`
` And as already happened, your counsel may
`
` object to any of my questions. You should go
`
` ahead and answer the question anyway unless your
`
` counsel specifically instructs you not to answer
`
` the question. Does that make sense?
`
` A I understand.
`
` Q I'll also try to take a break every hour
`
` or so, and then around lunch time for you, and not
`
` on my time zone, but please let me know if you
`
` need a break at any time. Does that sound okay?
`
` A Thank you.
`
` Q Dr. Pinal, have you ever provided
`
` testimony in an inter partes review proceeding?
`
` A Yes, to the extent of providing a
`
` declaration and nothing further than that.
`
` Q So you've never been deposed in an
`
` inter partes review before?
`
` A I have not.
`
` Q Have you submitted a declaration in more
`
` than one inter partes review proceeding outside of
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 10
`
`
`
`Page 11
`
` this one?
`
` A I have provided only one declaration in
`
` an inter partes proceeding prior to my work on
`
` this specific case.
`
` Q What was the subject matter of that one
`
` prior inter partes review proceeding that you
`
` submitted a declaration for?
`
` A The subject matter was on a formulation
`
` for a product that was administered buccally.
`
` (Discussion held off the record.)
`
` BY MS. KANNAPPAN:
`
` Q Do you remember what type of product that
`
` was?
`
` A I do.
`
` Q What type of product was it?
`
` A It was a thin film that was placed in the
`
` mouth.
`
` Q How long ago did you submit this
`
` declaration in that inter partes review?
`
` A Approximately four years ago.
`
` Q Do you know if that inter partes review
`
` resulted in a final decision?
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 11
`
`
`
`Page 12
`
` A I don't know the final outcome of that
`
` proceeding.
`
` Q Do you understand that you're here today
`
` to provide testimony in relation to the two
`
` declarations you filed in the inter partes review
`
` proceeding between Liquidia Technologies and
`
` United Therapeutics Corporation regarding U.S.
`
` patent number 9,604,901?
`
` A That is my understanding.
`
` Q And just to confirm, you understand that
`
` you filed two declarations in this proceeding,
`
` which I'll refer to as Exhibit 2002 and 2025; is
`
` that right?
`
` A The last digit number 2 and 25 are what I
`
` have in mind at this moment.
`
` Q Okay. In brief, could you summarize the
`
` differences between your two declarations?
`
` A The first declaration involved two
`
` patents which have similar -- well, they share
`
` the -- well, there is a legal term. The first
`
` part of the patent which is not the claims.
`
` Q The specification.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 12
`
`
`
`Page 13
`
` A The specification. Thank you. They
`
` share the specification and they have different
`
` claims.
`
` The subject that I have been asked to
`
` provide opinions for today's deposition focused on
`
` the '901 patent and the claims in that patent
`
` which were covered also in my first declaration.
`
` Q So would it be fair to say that your
`
` second declaration is consistent with your first
`
` one for the '901 patent, at least?
`
` A The technical and scientific principles
`
` of my first declaration and second declaration are
`
` shared between the two. The second declaration, I
`
` prepared it with additional evidence that was not
`
` available to me at the time of writing my first
`
` declaration.
`
` Q What additional evidence are you
`
` referring to?
`
` A For example, I had information regarding
`
` the testimony from Dr. Winkler I think that was
`
` not available to me at the time of writing my
`
` first declaration.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 13
`
`
`
`Page 14
`
` Q Do you mean the deposition testimony of
`
` Dr. Winkler?
`
` A The deposition testimony of Dr. Winkler
`
` is evidence that I did not have available to me at
`
` the time I wrote my first declaration.
`
` Q So other than the deposition testimony of
`
` Dr. Winkler, is there any additional evidence that
`
` you relied on in your second declaration, but not
`
` in your first?
`
` A Here's -- I am not a lawyer. All the
`
` materials that I considered in forming my opinions
`
` from my second declaration are listed in my
`
` declaration. So they include technical reports
`
` and technical writing.
`
` In a technical sense -- and I don't want
`
` to use the word if I don't know properly how to
`
` use it -- I don't know if those are evidence or
`
` not, but I will use my own words in answering your
`
` question. I considered some technical materials
`
` in addition to technical material that I
`
` considered at the time of my first declaration.
`
` Q Why did you consider additional technical
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 14
`
`
`
`Page 15
`
` materials in your second declaration, but not your
`
` first?
`
` A The first declaration involved two
`
` patents. And the commonalities in terms of
`
` technical argument between the two, some of them
`
` were shared; some of them were not necessarily
`
` shared. And the first declaration had, in terms
`
` of space, if you will, devoted to it, was slightly
`
` higher for the non-'901 patent than for the '901
`
` patent.
`
` On my second declaration, the focus is
`
` exclusively the '901 patent with the -- access to
`
` the testimony from Dr. Winkler and, in considering
`
` that new information or testimony, that guided me
`
` to find technical information that would help me
`
` in forming my opinions.
`
` Q Is it fair to say, then, that your second
`
` declaration is your full opinion on the '901
`
` patent?
`
` MR. TORCZON: Objection. Asked and
`
` answered. Objection. Form and foundation.
`
` THE WITNESS: My second declaration
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 15
`
`
`
` captures the -- my opinions as they were based on
`
` the information that I had and the time that I had
`
` to prepare them at the time when I signed that
`
`Page 16
`
` document.
`
` BY MS. KANNAPPAN:
`
` Q My question was a little different,
`
` Dr. Pinal. I'm just trying to figure out if
`
` that's, like, your complete universe of opinions.
`
` Is the second declaration the most complete form
`
` of your opinions on the '901 patent?
`
` MR. TORCZON: Objection. Form. Asked
`
` and answered.
`
` THE WITNESS: As I mentioned, the
`
` opinions as expressed in my second declaration
`
` capture the contents of my opinions as they were
`
` at the time of signing that document.
`
` BY MS. KANNAPPAN:
`
` Q So they include your opinions before that
`
` date as well; is that accurate?
`
` MR. TORCZON: Objection. Misstates.
`
` THE WITNESS: I'm sorry, I -- I don't
`
` think I understand your question.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 16
`
`
`
`Page 17
`
` BY MS. KANNAPPAN:
`
` Q Sure. I'm just trying to figure out if
`
` the pieces of your first declaration that were
`
` about the '901 patent were included in your second
`
` declaration so that we can treat your second
`
` declaration as the universe of your opinions going
`
` forward. Is that accurate?
`
` A No, that is not accurate.
`
` Q So what was in your first declaration
`
` that's not in your second declaration related to
`
` the '901 patent?
`
` A The point that is important is that, in
`
` your question, pieces of -- you referred to
`
` something like pieces. An opinion is not like
`
` made out of Lego pieces that you put together to
`
` create something. It is a concept that gets
`
` strengthened as information and consideration
`
` takes place.
`
` So when I referred to my first -- my
`
` opinions in my first declaration having the same
`
` technical principles as my second declaration --
`
` referred to that -- to the fundamental concepts
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 17
`
`
`
`Page 18
`
` but not necessarily as being fixed pieces.
`
` I have to connect my computer because
`
` it's giving me some trouble. Hold on. I have it
`
` connected throughout, but it's telling me that
`
` my -- and I apologize for this. It's telling me
`
` that my battery is running low.
`
` MS. KANNAPPAN: Can we go off the record
`
` just for a minute?
`
` THE VIDEOGRAPHER: Please stand by. The
`
` time is 11:27 a.m. We're going off the record.
`
` (Whereupon, a short recess was taken.)
`
` THE VIDEOGRAPHER: The time is 11:29 a.m.
`
` We are going back on the record.
`
` BY MS. KANNAPPAN:
`
` Q Dr. Pinal, were you finished answering
`
` the previous question?
`
` A I'm not sure, so let me just try to pick
`
` up where I recall I left.
`
` What I was saying was that the opinions
`
` are not small pieces that go -- so like in a --
`
` some structure that you build. Opinions are the
`
` result of a connection between different concepts
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 18
`
`
`
`Page 19
`
` and scientific principles, and they evolve. So
`
` even though the core of an opinion can be
`
` unchanged, the details and the specifics can get
`
` enriched by additional information and
`
` consideration.
`
` Q So sitting here -- I'm sorry. Go ahead.
`
` A This touches on your question that you
`
` asked me if the pieces or something -- I'm
`
` paraphrasing here -- the items or pieces of
`
` opinion, if they were the same. They are
`
` conceptually the same. They may not be
`
` articulated in exactly the same way.
`
` Q So to the extent there are differences
`
` between your first and second declaration, which
`
` declaration is the most current version of your
`
` opinion?
`
` A Well, I will answer that literally. The
`
` most current is the second one by virtue of it
`
` being the most recent.
`
` Q And do you have any reason to believe
`
` that there were any errors in your second
`
` declaration, sitting here today?
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 19
`
`
`
`Page 20
`
` A In terms of the concepts presented, I do
`
` not have a reason to believe that there were
`
` errors. There may have been some typographical
`
` errors or things of that sort, but not that I can
`
` think of that pertain to the actual concepts being
`
` presented.
`
` Q So there's no specific typographical
`
` errors or any other errors that you have caught in
`
` your review since filing that declaration; is that
`
` accurate?
`
` A Not changes that I would consider would
`
` be substantial corrections to my opinion, and
`
` specifically to the concepts being presented. I
`
` may have thought about perhaps better ways in
`
` terms of more clarity on how to present the
`
` concept, but not corrections in the sense that I
`
` find that something is wrong conceptually, perhaps
`
` typographically or something of that sort.
`
` Q Do you have specific errors that you're
`
` thinking of right now?
`
` A I do not have specific errors that I'm
`
` thinking of right now.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 20
`
`
`
`Page 21
`
` Q Dr. Pinal, what did you do to prepare to
`
` testify today?
`
` A I met with Mr. Torczon and Ms. Winschel
`
` and also with -- for some time with Mr. Shelton.
`
` Q How long in total did you meet with
`
` Mr. Torczon, Dr. Winschel and Mr. Shelton?
`
` A With Mr. Torczon and Dr. Winschel, I met
`
` for about one full day and about half a day.
`
` With -- Mr. Shelton was shorter, maybe a quarter
`
` of a day.
`
` Q Did you review any documents in preparing
`
` to testify today?
`
` A I reviewed the exhibits of my declaration
`
` and my declaration.
`
` Q Which declaration are you referring to?
`
` A My two declarations, and I focused
`
` primarily on my most recent declaration, which is
`
` the second declaration, and which focuses
`
` exclusively on the '901 patent.
`
` Q Did you review any documents that were
`
` not exhibits to your declarations?
`
` A I did not. The information that I had
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 21
`
`
`
`Page 22
`
` with me at all times was limited to the binders
`
` that I have, which include copies of my
`
` declarations and exhibits.
`
` Q Do you have any documents with you right
`
` now, Dr. Pinal?
`
` A I do.
`
` Q What documents do you have with you?
`
` A Let me show you. I have these type of --
`
` these type of binders that have hard copies of my
`
` declarations and the exhibits.
`
` Q Are there any annotations on those copies
`
` of your declarations and exhibits?
`
` A There are no annotations. What I have
`
` in -- not on the -- I will show you. I put these
`
` type of Post-It markers. In -- every place where
`
` you find in the text a new section or subsection,
`
` it would have one of these Post-Its. And the
`
` function of those Post-Its is to be able to move
`
` from one section or subsection without having to
`
` flip through single pages at that time. That
`
` is --
`
` Q Are there any --
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 22
`
`
`
`Page 23
`
` A I'm sorry.
`
` Q Go ahead.
`
` A That is -- those are all the
`
` modifications that have been made to the copies of
`
` these documents.
`
` Q And it doesn't look like you wrote
`
` anything on those Post-Its; is that right?
`
` A I have not written anything on any of
`
` those copies.
`
` Q Did you meet with anyone from UTC, United
`
` Therapeutics Corporation, in preparation for your
`
` deposition today?
`
` A I have never met, either in person or on
`
` video, anyone from United Therapeutics.
`
` Q Have you ever worked for or consulted for
`
` United Therapeutics Corporation?
`
` A I have no prior connection to United
`
` Therapeutics prior to these proceedings.
`
` Q Had you heard of United Therapeutics
`
` Corporation before this proceeding?
`
` A I may have, but I don't recall having
`
` heard about them.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 23
`
`
`
`Page 24
`
` Q Is it fair to say, then, that your first
`
` meaningful engagement with United Therapeutics
`
` Corporation is this proceeding?
`
` MR. TORCZON: Objection. Asked and
`
` answered.
`
` THE WITNESS: These proceedings are my
`
` first and only connection to United Therapeutics
`
` up to this moment.
`
` BY MS. KANNAPPAN:
`
` Q Have you ever worked for or consulted for
`
` Liquidia Technologies?
`
` A I have not.
`
` Q Are you aware of a parallel ongoing
`
` district court litigation between United
`
` Therapeutics Corporation and Liquidia Technologies
`
` involving the '901 patent?
`
` MR. TORCZON: Objection. Scope.
`
` THE WITNESS: I am not aware of what is
`
` going on between Liquidia and United Therapeutics
`
` outside of the materials that I have been asked to
`
` evaluate and opinions to --
`
` THE REPORTER: I'm sorry. After
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 24
`
`
`
`Page 25
`
` "material," could you please repeat what you said.
`
` THE WITNESS: That I have been asked to
`
` review and opinions to present.
`
` BY MS. KANNAPPAN:
`
` Q So you haven't reviewed any documents
`
` related to that district court litigation that I
`
` was referring to earlier?
`
` MR. TORCZON: Objection. Asked and
`
` answered.
`
` THE WITNESS: To the extent that any of
`
` those documents is also part of the exhibits that
`
` I have for these proceedings, no. I will not be
`
` able to answer that question because I don't have
`
` any information as to which materials are being
`
` reviewed in those proceedings. But if any of the
`
` proceedings that -- I'm sorry, if any of the
`
` exhibits that I have here with me now are being
`
` used in that case, then that will be, but I'm in
`
` no position to answer or even know.
`
` BY MS. KANNAPPAN:
`
` Q Did you review a declaration by Robert R.
`
` Ruffolo filed on February 5th, 2021?
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 25
`
`
`
`Page 26
`
` MR. TORCZON: Objection. Scope.
`
` THE WITNESS: I don't believe I ran into
`
` that declaration or writing from that author.
`
` BY MS. KANNAPPAN:
`
` Q Have you ever talked to a Dr. Robert R.
`
` Ruffolo?
`
` MR. TORCZON: Same objection.
`
` THE WITNESS: Robert what, sorry?
`
` BY MS. KANNAPPAN:
`
` Q R. Ruffolo. That's just the person's
`
` name.
`
` A No, I have never spoken to him.
`
` Q Are all the opinions that you offer in
`
` this proceeding set forth in your two
`
` declarations?
`
` MR. TORCZON: Objection. Asked and
`
` answered.
`
` THE WITNESS: As I mentioned before, the
`
` opinions in my declaration present the status of
`
` my thinking and consideration at the time when I
`
` signed that document.
`
` BY MS. KANNAPPAN:
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 26
`
`
`
`Page 27
`
` Q Are there opinions you have today that
`
` you didn't put in your two declarations?
`
` A As I mentioned before, opinions are the
`
` interconnection of different concepts and
`
` principles, and they evolve. So the subject of my
`
` opinions has not changed. The articulation may
`
` have been some changes; it's at the level that I
`
` cannot describe to you textually.
`
` Q Okay. So substantively are there any
`
` opinions today that you didn't put in your two
`
` declarations, anything you're thinking of?
`
` MR. TORCZON: Objection. Asked and
`
` answered.
`
` THE WITNESS: As I mentioned, the
`
` opinions as presented in my second declaration
`
` correspond to the opinions as I had them
`
` articulated at the time when I signed that
`
` document.
`
` BY MS. KANNAPPAN:
`
` Q Dr. Pinal, that wasn't my question. My
`
` question is whether you have any opinions today
`
` that are different from the day you signed your
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 27
`
`
`
`Page 28
`
` last declaration, substantively?
`
` MR. TORCZON: Same objection.
`
` THE WITNESS: As I mentioned to you,
`
` opinions are the result of interconnection of
`
` scientific principles and concepts and they
`
` evolve. So the opinions that I have presented in
`
` my second declaration are still today my opinions.
`
` The actual articulation of the opinions that you
`
` have in my report are presented in the shape as
`
` they were articulated at the time when I signed
`
` that document.
`
` BY MS. KANNAPPAN:
`
` Q Okay. So they're -- strike that.
`
` As you sit here today, do you have any
`
` opinions about the issues in this proceeding that
`
` are not included in those two declarations?
`
` MR. TORCZON: Same objection.
`
` THE WITNESS: The general concepts
`
` presented in my opinions as expressed in my second
`
` declaration are still my opinions today. And over
`
` the time to -- given to consider and review, there
`
` can be some evolution of the opinions.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 28
`
`
`
`Page 29
`
` The main concepts technically of the
`
` opinions remain. The articulation may change in a
`
` way that I cannot describe to you textually.
`
` BY MS. KANNAPPAN:
`
` Q Are there any other bases for your
`
` opinions that are not set forth in your
`
` declarations?
`
` A Let me see if I understand. Are there
`
` any more bases for -- for my declarations?
`
` Q Yeah. Are there any other bases for your
`
` opinions? So you've talked a lot about the
`
` concepts, that those are consistent but that the
`
` articulation might change. And so my question is,
`
` are there any other bases for your opinions that
`
` are not set forth in your declarations?
`
` MR. TORCZON: Objection. Form.
`
` THE WITNESS: The bases for my opinions
`
` are listed in the -- and included in the exhibits
`
` that I have used for forming my opinions.
`
` BY MS. KANNAPPAN:
`
` Q So is that a no?
`
` MR. TORCZON: Objection. Asked and
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`Veritext Legal Solutions
`215-241-1000 ~ 610-434-8588 ~ 302-571-0510 ~ 202-803-8830
`
`Liquidia's Exhibit 1018
`IPR2020-00770
`Page 29
`
`
`
`Page 30
`
` answered.
`
` THE WITNESS: No, what?
`
` BY MS. KANNAPPAN:
`
` Q No, there aren't other bases that weren't
`
` included either as exhibits or in your actual
`
` declaration?
`
` A I will give you the best answer I can.
`
` And the best answer I can give you is this: All
`
` the bases for my opinions presented in my
`
` declaration are included with a list of exhibits
`
` presente